Atricure Inc (ATRC)
Atricure stock today
Atricure closed at $61.25 on October 30, 2026, down 1.97% on the day. Over the past year it returned +79.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $3.10 billion.
| Period | ATRC | S&P 500 (SPY) |
|---|---|---|
| 1 month | +9.0% | -0.9% |
| 3 months | +52.6% | +2.1% |
| Year to date | +54.8% | +11.7% |
| 1 year | +79.7% | +12.4% |
| 3 years | +82.7% | +88.5% |
| 5 years | -18.4% | +76.0% |
Key statistics
- Market value
- $3.10B
- P/E (trailing)
- 291.7
- Forward P/E
- 170.7
- Price / sales
- 5.5
- 52-week range
- $25.86 to $62.48
- Next report
- Nov 3, 2026
About Atricure
AtriCure develops and sells medical devices for surgical ablation and occlusion therapies.
Sector: Health Care
More on Atricure
- Financials: revenue, earnings and segmentsRevenue +15% in the year to Dec 2025
- Valuation: P/E history and peersP/E 291.7
- Returns: what $1,000 became$1,000 ten years ago is $3,464 today
No forecast, no recommendation. This page describes Atricure Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.